News

UC Riverside experts discuss disease symptoms, vaccines, and anxiety management

UC Riverside vaccine expert David Lo shares his thoughts in a Q&A

SAVE focuses on mutations in SARS-CoV-2 and emerging virus variants

UC Riverside’s Dr. David Lo, a vaccine expert, shares his thoughts

UC Riverside-led study shows how an effective therapy against SARS-CoV-2 could be developed

New method developed by UC Riverside researchers quickly assesses drug potential for rare disorders

Joint effort by UC Riverside and UCLA scientists aims to stop the COVID-19-spreading virus from attacking immune cells

UC Riverside-led team identifies a new host protein interaction that produces a robust immune response to viral infection in birds and may lead to better poultry vaccines

As the COVID-19 pandemic continues, the development of antiviral drug treatments has become a critical weapon in our arsenal against the virus. Harnessing the research and scientific brainpower needed to treat and prevent the next pandemic is the University of California - National Labs Antiviral Treatments Targeting All Coronaviruses and...

UC Riverside mouse study focuses on the receptor TNFR1

UC Riverside research shows gene reactivation can be used to treat Fragile X syndrome

UC Riverside-led team identifies molecular driver and protector of this life-threatening medical emergency

Lei Stanley Qi of Stanford University will give the 2021 Thomas and Salma Haider Biomedical Breakthrough Lecture at UC Riverside

UC Riverside-led study in mice and human tissue is the first to show how a disease mutation weakens barrier properties of epithelial cells lining the gut

UC Riverside experts share their thoughts

UC Riverside mouse study suggests inflammation could play key role in progression to asthma

PANDORA sequencing method developed by UC Riverside-led team can detect once-undetectable small RNAs

UC Riverside biomedical scientists were part of an international team that identified the coronavirus strain

Immunity generated by vaccination is better than immunity from an actual infection, says an expert

UC Riverside-led mouse study stresses MS treatment should be started early